Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 6
RESEARCH METHODOLOGY
2.1.1 SECONDARY DATA
•
The secondary sources referred to for this research study include government sources such as World Health
Organization (WHO), Organization for Economic Co-operation and Development (OECD), the World Bank, and
the U.S. Census Bureau, among others; corporate filings (annual reports, SEC filings, investor presentations, and
financial statements); and trade, business, and professional associations. Secondary data was collected and
analyzed to arrive at the overall market size of the global human insulin market, which was validated by primary
research.
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
2.1.2 PRIMARY DATA
•
Extensive primary research was conducted after acquiring basic knowledge on the global human insulin market
scenario through secondary research. Several primary interviews were conducted with market experts from both
demand (hospitals, clinics, healthcare facility providers, trauma centers, and research organizations) and supply
sides (human insulin product manufacturers, distributors, and marketing companies) across four major regions—
North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, the Middle East, and Africa).
Approximately 35% and 65% primary interviews were conducted from the demand- and supply-side participants,
respectively. This primary data was collected through questionnaires, mails, and telephonic interviews.
•
[email protected]
www.marketsandmarkets.com
6